vs
景顺（IVR）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
景顺的季度营收约是Laird Superfood, Inc.的1.6倍（$21.3M vs $13.3M），景顺净利率更高（242.2% vs -13.2%，领先255.4%），景顺同比增速更快（55.4% vs 15.0%），过去两年景顺的营收复合增速更高（74.2% vs 16.1%）
景顺是一家美国独立投资管理公司，总部位于佐治亚州亚特兰大，在全球20个国家设有分支机构。景顺旗下拥有景顺、景顺 perpetual、PowerShares等多个品牌，其普通股纳入标普500指数，在纽约证券交易所挂牌交易。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
IVR vs LSF — 直观对比
营收规模更大
IVR
是对方的1.6倍
$13.3M
营收增速更快
IVR
高出40.4%
15.0%
净利率更高
IVR
高出255.4%
-13.2%
两年增速更快
IVR
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.3M | $13.3M |
| 净利润 | $51.5M | $-1.8M |
| 毛利率 | — | 34.1% |
| 营业利润率 | — | -13.5% |
| 净利率 | 242.2% | -13.2% |
| 营收同比 | 55.4% | 15.0% |
| 净利润同比 | 1368.7% | -341.4% |
| 每股收益（稀释后） | $0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVRLSF
| Q4 25 | $21.3M | $13.3M | ||
| Q3 25 | $17.6M | $12.9M | ||
| Q2 25 | $17.7M | $12.0M | ||
| Q1 25 | $18.8M | $11.7M | ||
| Q4 24 | $13.7M | $11.6M | ||
| Q3 24 | $7.5M | $11.8M | ||
| Q2 24 | $8.6M | $10.0M | ||
| Q1 24 | $7.0M | $9.9M |
净利润IVRLSF
| Q4 25 | $51.5M | $-1.8M | ||
| Q3 25 | $53.5M | $-975.1K | ||
| Q2 25 | $-23.3M | $-362.2K | ||
| Q1 25 | $19.6M | $-156.2K | ||
| Q4 24 | $3.5M | $-398.4K | ||
| Q3 24 | $40.7M | $-166.1K | ||
| Q2 24 | $-13.5M | $-239.1K | ||
| Q1 24 | $29.1M | $-1.0M |
毛利率IVRLSF
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率IVRLSF
| Q4 25 | — | -13.5% | ||
| Q3 25 | — | -7.7% | ||
| Q2 25 | — | -3.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | — | -4.1% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -11.0% |
净利率IVRLSF
| Q4 25 | 242.2% | -13.2% | ||
| Q3 25 | 303.6% | -7.6% | ||
| Q2 25 | -131.6% | -3.0% | ||
| Q1 25 | 104.4% | -1.3% | ||
| Q4 24 | 25.6% | -3.4% | ||
| Q3 24 | 542.2% | -1.4% | ||
| Q2 24 | -155.9% | -2.4% | ||
| Q1 24 | 415.9% | -10.3% |
每股收益（稀释后）IVRLSF
| Q4 25 | $0.72 | — | ||
| Q3 25 | $0.74 | — | ||
| Q2 25 | $-0.40 | — | ||
| Q1 25 | $0.26 | — | ||
| Q4 24 | $-0.09 | — | ||
| Q3 24 | $0.63 | — | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $0.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $56.0M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $797.5M | $11.5M |
| 总资产 | $6.5B | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IVRLSF
| Q4 25 | $56.0M | $5.1M | ||
| Q3 25 | $58.5M | $5.1M | ||
| Q2 25 | $59.4M | $3.9M | ||
| Q1 25 | $42.9M | $7.0M | ||
| Q4 24 | $73.4M | $8.3M | ||
| Q3 24 | $48.3M | $7.9M | ||
| Q2 24 | $58.8M | $7.6M | ||
| Q1 24 | $59.9M | $7.1M |
股东权益IVRLSF
| Q4 25 | $797.5M | $11.5M | ||
| Q3 25 | $769.6M | $12.8M | ||
| Q2 25 | $709.4M | $13.4M | ||
| Q1 25 | $759.2M | $13.3M | ||
| Q4 24 | $730.7M | $13.2M | ||
| Q3 24 | $857.0M | $13.1M | ||
| Q2 24 | $759.2M | $12.6M | ||
| Q1 24 | $785.6M | $12.7M |
总资产IVRLSF
| Q4 25 | $6.5B | $19.2M | ||
| Q3 25 | $6.0B | $18.9M | ||
| Q2 25 | $5.4B | $20.4M | ||
| Q1 25 | $6.2B | $21.5M | ||
| Q4 24 | $5.7B | $19.3M | ||
| Q3 24 | $6.1B | $18.8M | ||
| Q2 24 | $5.1B | $18.0M | ||
| Q1 24 | $5.2B | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $157.1M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.05× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IVRLSF
| Q4 25 | $157.1M | $68.4K | ||
| Q3 25 | $37.3M | $1.2M | ||
| Q2 25 | $40.6M | $-2.8M | ||
| Q1 25 | $19.3M | $-1.3M | ||
| Q4 24 | $183.2M | $339.2K | ||
| Q3 24 | $30.8M | $305.8K | ||
| Q2 24 | $33.0M | $642.7K | ||
| Q1 24 | $57.5M | $-422.3K |
现金转化率IVRLSF
| Q4 25 | 3.05× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 52.24× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IVR
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
